IQVIA
Clinical Trial Services (CRO) · Health Data & Interoperability

IQVIA: Funding & valuation

IQVIA has $244k paid in by investors, lenders and donors.

Financials

Revenue of $16.3B in 2025. +5.9% on the year before. Net income $1.4B.

$16.3BRevenue2025 · +5.9%
$1.4BNet income2025 · −0.9%
93,000Employees2025
Revenue by yearas filed, with the net income
2025$16.3Bnet income $1.4B
2024$15.4Bnet income $1.4B
2023$15Bnet income $1.4B
2022$14.4Bnet income $1.1B
2021$13.9Bnet income $966M
2020$11.4Bnet income $279M
2019$11.1Bnet income $191M
2018$10.4Bnet income $259M
Sources: SEC

Money

IQVIA has $244k paid in by investors, lenders and donors.

$244kPaid in
$1.2BDividends and buybacksFY2025
$603MCapital expenditureFY2025
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Loan or credit · Moelis Asset Management
Jun 2026 · Loan from Steele Creek Capital Corp
$244kPaid
Loan or credit · Station House Bracknell Limited and Station House (Nominees) Limited
Jun 2004 – Apr 2023 · Charge: Deed of confirmation and charge
not statedPaid
Loan or credit · Boehringer Mannheim UK Limited
May 1998 – Jul 2005 · Charge: A standard security which was presented for registration in scotland on 10 june 1998 and
not statedPaid
From its filingssec.gov ↗
FY2023FY2024FY2025
Income taxes paid$340M$295M–
Shares bought back$992M$1.4B$1.2B
Capital expenditure$649M$602M$603M
Stock-based compensation$217M$206M$247M
Acquisitions, net of cash$876M$735M$1.7B
Taxes
IQVIA RDS Finland Oy
2025 · Finnish Tax Administration · vero.fi ↗
$109k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".